449 related articles for article (PubMed ID: 15339768)
21. "Hook effect" in complete hydatidiform molar pregnancy: a falsely low level of beta-HCG.
Levavi H; Neri A; Bar J; Regev D; Nordenberg J; Ovadia J
Obstet Gynecol; 1993 Oct; 82(4 Pt 2 Suppl):720-1. PubMed ID: 7690921
[TBL] [Abstract][Full Text] [Related]
22. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
[TBL] [Abstract][Full Text] [Related]
23. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study.
Kim BW; Cho H; Kim H; Nam EJ; Kim SW; Kim S; Kim YT; Kim JH
Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909
[TBL] [Abstract][Full Text] [Related]
24. The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles.
Baasanjav B; Usui H; Kihara M; Kaku H; Nakada E; Tate S; Mitsuhashi A; Matsui H; Shozu M
Hum Reprod; 2010 May; 25(5):1183-91. PubMed ID: 20208060
[TBL] [Abstract][Full Text] [Related]
25. What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients.
Coyle C; Short D; Jackson L; Sebire NJ; Kaur B; Harvey R; Savage PM; Seckl MJ
Gynecol Oncol; 2018 Feb; 148(2):254-257. PubMed ID: 29229282
[TBL] [Abstract][Full Text] [Related]
26. Duration of human chorionic gonadotropin surveillance for partial hydatidiform moles.
Lavie I; Rao GG; Castrillon DH; Miller DS; Schorge JO
Am J Obstet Gynecol; 2005 May; 192(5):1362-4. PubMed ID: 15902109
[TBL] [Abstract][Full Text] [Related]
27. Predictors of persistent disease in women with complete hydatidiform mole.
Ayhan A; Tuncer ZS; Halilzade H; Küçükali T
J Reprod Med; 1996 Aug; 41(8):591-4. PubMed ID: 8866387
[TBL] [Abstract][Full Text] [Related]
28. Human chorionic gonadotropin follow-up in patients with molar pregnancy: a time for reevaluation.
Feltmate CM; Batorfi J; Fulop V; Goldstein DP; Doszpod J; Berkowitz RS
Obstet Gynecol; 2003 Apr; 101(4):732-6. PubMed ID: 12681878
[TBL] [Abstract][Full Text] [Related]
29. Gestational Trophoblastic Neoplasia After Human Chorionic Gonadotropin Normalization Following Molar Pregnancy: A Systematic Review and Meta-analysis.
Albright BB; Shorter JM; Mastroyannis SA; Ko EM; Schreiber CA; Sonalkar S
Obstet Gynecol; 2020 Jan; 135(1):12-23. PubMed ID: 31809433
[TBL] [Abstract][Full Text] [Related]
30. Outcome of pregnancies occurring before completion of human chorionic gonadotropin follow-up in patients with persistent gestational trophoblastic tumor.
Tuncer ZS; Bernstein MR; Goldstein DP; Berkowitz RS
Gynecol Oncol; 1999 Jun; 73(3):345-7. PubMed ID: 10366457
[TBL] [Abstract][Full Text] [Related]
31. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
Kohorn EI; Kacinski BM; Stanley ER
Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
[TBL] [Abstract][Full Text] [Related]
32. Analysis of risk factors for persistent gestational trophoblastic disease.
Khoo SK; Baartz D; Sidhu M; Yip WL; Tripcony L
Aust N Z J Obstet Gynaecol; 2009 Dec; 49(6):657-9. PubMed ID: 20070718
[TBL] [Abstract][Full Text] [Related]
33. Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma.
Kohorn EI
Gynecol Oncol; 2002 May; 85(2):315-20. PubMed ID: 11972394
[TBL] [Abstract][Full Text] [Related]
34. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
[TBL] [Abstract][Full Text] [Related]
35. Clinical features of early-stage nonhydropic mole for diagnosis of persistent trophoblastic disease.
Miyoshi J; Ohba T; Fukunaga M; Katabuchi H
Obstet Gynecol; 2011 Oct; 118(4):847-53. PubMed ID: 21934448
[TBL] [Abstract][Full Text] [Related]
36. Serum relaxin in patients with hydatidiform mole.
Seki K; Uesato T; Tabei T; Kato K
Obstet Gynecol; 1986 Mar; 67(3):381-3. PubMed ID: 3945450
[TBL] [Abstract][Full Text] [Related]
37. What we know about low-level hCG: definition, classification and management.
Kohorn EI
J Reprod Med; 2004 Jun; 49(6):433-7. PubMed ID: 15283049
[TBL] [Abstract][Full Text] [Related]
38. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
[TBL] [Abstract][Full Text] [Related]
39. [Radioimmunoassay of beta sub unit HCG following hydatidiform mole or chorionic carcinoma (author's transl)].
Tscherne G; Pürstner P
Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):704-8. PubMed ID: 478273
[TBL] [Abstract][Full Text] [Related]
40. Development of postmolar trophoblastic disease after partial molar pregnancy.
Goto S; Yamada A; Ishizuka T; Tomoda Y
Gynecol Oncol; 1993 Feb; 48(2):165-70. PubMed ID: 8428686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
